Trials / Recruiting
RecruitingNCT05345457
Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 88 (estimated)
- Sponsor
- University Hospitals Cleveland Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A randomized, controlled, non-placebo trial to primarily assess the effect of oral, outpatient antibiotics (i.e., azithromycin and amoxicillin) on latency (i.e., proportion of patients that deliver within 28 days from membrane rupture) following previable, prelabor rupture of membranes between 18 0/7 and 22 6/7 weeks gestational age.
Conditions
- Pregnancy Preterm
- Pregnancy Prom
- PROM, Preterm (Pregnancy)
- PROM (Pregnancy)
- Premat Rupture Membranes Preterm Unspec to Length of Time Between Rupture/Labor
- Premature Birth
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin Pill | Azithromycin will be dosed as single 500 mg dose (2-250mg oral tablets) administered immediately following randomization, yet prior to discharge to home, followed with 1-250mg oral tablet daily for 4 additional days (for a total of 5 days). |
| DRUG | Amoxicillin Pill | Amoxicillin will be dosed as a single-500mg oral tablet three times daily for 7 days with first dose also being given prior to discharge home. |
Timeline
- Start date
- 2023-01-13
- Primary completion
- 2026-06-01
- Completion
- 2027-06-01
- First posted
- 2022-04-26
- Last updated
- 2025-04-22
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05345457. Inclusion in this directory is not an endorsement.